Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | NOL9 |
| Upstream (Parents) |
|---|
| (<<) CBFA2T3 → NOL9 |
| (<<) MYC → NOL9 |
| (<<) NOC3L → NOL9 |
| (<<) PDE2A → NOL9 |
| (<<) PRKCZ → NOL9 |
| (<<) RPS6KA1 → NOL9 |
| (<<) RRP1 → NOL9 |
| (<<) SYNPO → NOL9 |
| (<<) TP53 → NOL9 |
| (<<) TUBA1C → NOL9 |
| Downstream (Children) |
|---|
| NOL9 → APH1B (>>) |
| NOL9 → CASP10 (>>) |
| NOL9 → CENPF (>>) |
| NOL9 → CHODL (>>) |
| NOL9 → CRTC1 (>>) |
| NOL9 → ERBB2 (>>) |
| NOL9 → GRB7 (>>) |
| NOL9 → GRK5 (>>) |
| NOL9 → GSK3A (>>) |
